MSCI 2026 Rebalancing: A Deep Dive into Indonesia’s Index ‘Purge’

Global markets were sent a clear signal this week as MSCI Inc. announced the results of its May 2026 Semi-Annual Index Review. In a significant shift for the Jakarta Composite Index (JCI), a total of 19 Indonesian stocks were removed from the Global Standard and Small Cap indices, effective after the market close on May 29, 2026.

Key Insight: The rebalancing is expected to trigger passive outflows estimated between $1.3 billion and $2 billion as global funds tracking these indices adjust their portfolios

The Standard Index ShiftSix prominent names were removed from the MSCI Global Standard Index. This list includes high-profile energy and infrastructure players that have dominated local trading volumes recently.

  • AMMN (Amman Mineral Internasional): Removed
  • BREN (Barito Renewables Energy): Removed
  • TPIA (Chandra Asri Pacific): Removed
  • DSSA (Dian Swastatika Sentosa): Removed
  • CUAN (Petrindo Jaya Kreasi): Removed
  • AMRT (Sumber Alfaria Trijaya): Downgraded to Small Cap

Small Cap Index Deletions

The Small Cap segment saw 13 deletions, spanning sectors from retail and healthcare to agribusiness. These removals reflect tightening liquidity and free-float requirements. Notable retail and consumer names removed include SIDO, MIDI, and MIKA. Other deletions include ANTM, AALI, BANK, BSDE, DSNG, MSIN, SSMS, TKIM, APIC, and TAPG.

Why Now? The “HSC” Concern

The removals are largely attributed to MSCI’s scrutiny of High Shareholding Concentration (HSC). Stocks with low free-float transparency or those where a few majority owners hold the vast majority of shares are increasingly being filtered out to protect global investors from volatility and liquidity risks. This move is seen as a precursor to the MSCI Market Accessibility Review in June, which will evaluate if Indonesia maintains its status as an “Emerging Market”.

Source: MSCI May 2026 Index Review Data. 

Disclaimer: The information provided in this article is for general informational and educational purposes only and does not constitute financial, investment, or legal advice.

Dr IM